RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED)
Considerations from the FDA Sentinel Innovation Center
Desai, R. J., Wang, S., Sreedhara, S. K., Zabotka, L., Khosrow-Khavar, F., Nelson, J. C., Shi, X., Toh, S., Wyss, R., Patorno, E., Dutcher, S., Li, J., Lee, H., Ball, R., Dal Pan, G., Segal, J. B., Suissa, S., Rothman, K. J., Greenland, S., ... Schneeweiss, S. (2024). Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): Considerations from the FDA Sentinel Innovation Center. Bmj-british Medical Journal, 384, Article e076460. https://doi.org/10.1136/bmj-2023-076460
This report proposes a stepwise process covering the range of considerations to systematically consider key choices for study design and data analysis for noninterventional studies with the central objective of fostering generation of reliable and reproducible evidence. These steps include (1) formulating a well defined causal question via specification of the target trial protocol; (2) describing the emulation of each component of the target trial protocol and identifying fit -for -purpose data; (3) assessing expected precision and conducting diagnostic evaluations; (4) developing a plan for robustness assessments including deterministic sensitivity analyses, quantitative bias analyses, and net bias evaluation; and (5) inferential analyses.
